Miracor Medical is a European medical device company originally founded in Austria and now headquartered in Awans, Belgium, specializing in innovative therapies for severe cardiac conditions. Its flagship product, the PiCSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System, is designed to reduce infarct size and improve heart function in patients experiencing ST-elevation myocardial infarction (STEMI) by intermittently occluding the coronary sinus during percutaneous coronary intervention (PCI). The PiCSO system has received CE marking in Europe and was granted FDA Breakthrough Device designation in the U.S., with ongoing clinical trials evaluating its efficacy in both anterior and inferior STEMI patients.
Miracor
27
May
May
